What are the key factors for the success of de novo protein sequencing? An in-depth exploration

De Novo Sequencing, a technology for directly analyzing protein amino acid sequences, has become an indispensable tool in fields such as non-model organism research, antibody drug development, protein mutation, and modification identification. Its success depends on the coordination of multiple aspects including sample preparation, mass spectrometry analysis, data interpretation, and algorithm optimization. This article systematically analyzes the core factors affecting the success of De Novo Sequencing, providing researchers with comprehensive technical references.

 

1. Sample Quality and Preparation

The first step of De Novo Sequencing is to ensure high-quality samples and appropriate preparation methods. The complexity of the sample, the degradation of proteins, and the uniformity of peptides directly affect the accuracy of sequencing.

(1) Sample Purity Control

High-quality samples are the prerequisite for successful De Novo Sequencing. To prevent protein degradation, protease inhibitors should be added during extraction and handling, operations should be conducted at low temperatures, and sample storage time should be minimized. To remove interfering components such as salts, detergents, and nucleic acids, purification methods such as ultrafiltration, dialysis, and gel filtration should be used to enhance the quality of mass spectrometry data.

 

(2) Protease Digestion Strategy

Using a combination of proteases (such as trypsin, Glu-C, Asp-N, Lys-C) can yield peptide fragments with different cleavage sites, improving sequence coverage. For difficult-to-analyze regions, the introduction of nonspecific proteases can help obtain more fragment information, although the complexity of the data will increase.

 

(3) Enrichment of Low-Abundance Proteins

In complex samples (such as plasma or tissue lysates), to enhance the detection sensitivity of target proteins, high-abundance proteins can be removed or selective enrichment methods such as immunoaffinity purification and column chromatography can be used to enhance the detection signals of low-abundance proteins.

 

2、Optimization of Mass Spectrometry Analysis

High-resolution and high-sensitivity mass spectrometers (MS) are the foundation for successful De Novo Sequencing, with the key being suitable fragmentation modes, instrument resolution, and data acquisition strategies.

(1) Selection of High-Resolution Mass Spectrometers

De Novo Sequencing relies on high-resolution tandem mass spectrometry (MS/MS), with Orbitrap and FT-ICR MS being preferred due to their superior mass resolution (>100,000) and accuracy (ppm level). TOF (Time-of-Flight) and Q-TOF instruments are also commonly used for De Novo Sequencing, offering high detection speeds and wide m/z coverage ranges.

 

(2) Optimization of Fragmentation Modes

Different mass spectrometry fragmentation modes have varying capabilities for peptide analysis. Common fragmentation methods include:

• Collision-Induced Dissociation (CID): Primarily produces b ions and y ions, suitable for short peptides, but has low sensitivity to post-translational modifications (PTMs).

• Higher-Energy Collisional Dissociation (HCD): Generates more complete b and y ion sequences while preserving post-translational modification information.

• Electron Transfer Dissociation (ETD): Suitable for large molecules and highly modified peptides, capable of retaining post-translational modification information (such as phosphorylation and glycosylation).

 

(3) Data Acquisition Strategies

• Data-Dependent Acquisition (DDA): Selects the strongest precursor ions for fragmentation, suitable for high-abundance proteins.

• Data-Independent Acquisition (DIA): Scans all peptide fragments, suitable for De Novo Sequencing of low-abundance proteins.

• Targeted Data Acquisition (PRM, SRM): Used for in-depth analysis of specific proteins, reducing background interference.

 

3. Data Interpretation and Algorithm Optimization

(1) Ion Matching and Spectrum Interpretation

Evaluate the interpretability of peptide fragments through the integrity of b/y ion series. If certain amino acids fail to detect corresponding ion peaks, sequence stitching errors may occur. Mass error control: Use high-resolution MS data (such as Orbitrap) to reduce error margins and ensure matching accuracy.

 

(2) Algorithm Optimization

Currently, computational methods for De Novo Sequencing include:

• Spectrum Graph Approach: Constructs connections between fragment ions to deduce peptide sequences.

• Scoring Functions: Uses statistical models to calculate optimal sequence matching results, with software like pNovo and PEAKS using Bayesian models to optimize matching probabilities.

• Machine Learning and Deep Learning: In recent years, artificial intelligence (AI) has gradually been applied to De Novo Sequencing. Tools like DeepNovo use neural networks for sequence prediction, enhancing the interpretation capabilities of complex spectra.

 

(3) Analysis of Post-Translational Modifications (PTMs)

Modified amino acids often cause shifts in the m/z of peptide fragments, requiring algorithms to account for mass shifts caused by modifications, such as phosphorylation (+79.97 Da) and acetylation (+42.01 Da). ETD fragmentation is commonly used to identify post-translational modifications, combined with high-resolution mass spectrometry data to improve the precision of modification site localization.

 

4. Result Validation and Data Integration

(1) Sequence Stitching

Different peptide fragment combinations may affect the final protein sequence. Experiments typically compare results from digestion with different proteases to obtain a more complete sequence.

 

(2) Database Comparison

Although the goal of De Novo Sequencing is to be independent of databases, existing protein databases (such as Uniprot) can still be used for cross-validation to ensure accuracy.

 

(3) Functional Validation

Perform biological experiments (such as Western Blot, ELISA, structure modeling) on the sequenced proteins to ensure the interpreted sequence aligns with its biological function.

 

With continuous advancements in high-resolution mass spectrometry, deep learning algorithms, and methods for analyzing post-translational modifications, the accuracy and efficiency of De Novo Sequencing will continue to improve.Biotech Pack BiotechnologyWe provide De Novo Sequencing services to a wide range of customers. Our 'one-stop' service can save you time and effort, helping you conduct related research more efficiently.

 

Biotech Pack Biotechnology--Characterization of Bioproducts, High-Quality Mass Spectrometry Services for Multi-omics

 

Related Services: